| __timestamp | CRISPR Therapeutics AG | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 2704597 |
| Thursday, January 1, 2015 | 12573000 | 15470000 |
| Friday, January 1, 2016 | 42238000 | 28037000 |
| Sunday, January 1, 2017 | 69800000 | 71615000 |
| Monday, January 1, 2018 | 113773000 | 99828000 |
| Tuesday, January 1, 2019 | 179362000 | 166023000 |
| Wednesday, January 1, 2020 | 266946000 | 201727000 |
| Friday, January 1, 2021 | 438633000 | 259039000 |
| Saturday, January 1, 2022 | 461645000 | 294781000 |
| Sunday, January 1, 2023 | 387332000 | 344077000 |
| Monday, January 1, 2024 | 320653000 |
Unleashing the power of data
In the rapidly evolving biotech sector, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, CRISPR Therapeutics AG and Iovance Biotherapeutics, Inc. have been at the forefront of this trend. Since 2014, CRISPR Therapeutics has increased its R&D spending by an impressive 25,500%, peaking in 2022. Meanwhile, Iovance Biotherapeutics has also shown a significant rise, with a 12,600% increase over the same period. By 2023, CRISPR's R&D budget was approximately 13% higher than Iovance's, highlighting its aggressive pursuit of cutting-edge genetic therapies. This data underscores the competitive nature of the biotech industry, where strategic R&D investments can be the key to unlocking groundbreaking treatments. As these companies continue to innovate, their R&D trajectories offer valuable insights into the future of biotechnology.
Analyzing R&D Budgets: Pfizer Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Sanofi vs Iovance Biotherapeutics, Inc.
R&D Insights: How Biogen Inc. and CRISPR Therapeutics AG Allocate Funds
R&D Spending Showdown: Summit Therapeutics Inc. vs Iovance Biotherapeutics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and CRISPR Therapeutics AG Allocate Funds
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: CRISPR Therapeutics AG vs Dynavax Technologies Corporation
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Veracyte, Inc. vs Iovance Biotherapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.
ImmunityBio, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?